-
公开(公告)号：US20180104295A1
公开(公告)日：2018-04-19
申请号：US15785267
申请日：2017-10-16
CPC分类号： A61K36/28 , A61K35/20 , A61K35/38 , A61K36/285 , A61K2300/00
摘要： A therapeutic composition for wet and dry gangrene includes an herbal composition alone, or in combination with one or more animal-derived products. The herbal composition can include a mixture of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The mixture can include, for example, a mixture of extracts or whole herbs of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The one or more animal-derived products can include at least one of camel milk and camel saliva.
-
公开(公告)号：US09999643B2
公开(公告)日：2018-06-19
申请号：US15785267
申请日：2017-10-16
IPC分类号： A61K36/28 , A61K36/285 , A61K35/20 , A61K35/38
CPC分类号： A61K36/28 , A61K35/20 , A61K35/38 , A61K36/285 , A61K2300/00
摘要： A therapeutic composition for wet and dry gangrene includes an herbal composition alone, or in combination with one or more animal-derived products. The herbal composition can include a mixture of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The mixture can include, for example, a mixture of extracts or whole herbs of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The one or more animal-derived products can include at least one of camel milk and camel saliva.
-
3.发明申请公开(公告)号：US20160235802A1
公开(公告)日：2016-08-18
申请号：US14903277
申请日：2013-08-29
申请人： Kuan-chih CHOW
发明人： Kuan-Chih Chow
IPC分类号： A61K36/69 , A61K9/16 , A61K36/258 , A61K36/076 , A61K36/481 , A61K36/484 , A61K36/725 , A61K36/185 , A61K36/232 , A61K36/9068 , A61K36/906 , A61K9/00 , A61K36/284
CPC分类号： A61K36/69 , A61K9/0053 , A61K9/0095 , A61K9/16 , A61K36/076 , A61K36/185 , A61K36/232 , A61K36/258 , A61K36/284 , A61K36/285 , A61K36/481 , A61K36/484 , A61K36/725 , A61K36/77 , A61K36/906 , A61K36/9068 , A61K2236/33 , A61K2236/331 , A61K2236/37 , A61K2236/53 , A61K2300/00
摘要： A Chinese medicine capable of triggering lung adenocarcinoma cell autophagy mainly uses a polygala tenuifolia willd herb with a quantity depending on a patient's physical fitness and sickness conditions determined by a doctor, and capable of triggering a lung adenocarcionma cell autophagy (cracking) to achieve a treatment effect. Regardless of being taken as a powder or an extract, the medicine is capable of triggering the adenocarcionma cell autophagy (cracking) effect to achieve the treatment effect. The polygala tenuifolia willd applies a new protein transport mode as a target enzyme screening to successfully prove the effect of triggering lung adenocarcionma cell autophagy (cracking) for cancer treatment.
摘要翻译： 能够引发肺腺癌细胞自噬的中药主要使用一种根据医生确定的患者身体健康状况和疾病状况的多药耐药草药，并能够引发肺腺癌细胞自噬（破裂）以达到治疗 影响。 无论将其作为粉末或提取物，药物都能够引发腺癌细胞自噬（裂解）效应，达到治疗效果。 Polygala tenuifolia willd应用新的蛋白质转运模式作为靶酶筛选，以成功证明触发肺腺癌细胞自噬（裂解）对癌症治疗的作用。
-
4.发明申请公开(公告)号：US20160008406A1
公开(公告)日：2016-01-14
申请号：US14771505
申请日：2014-06-12
申请人： Zhuangcun GAO , Xiangyu GAO
发明人： Zhuangcun Gao , Xiangyu Gao
IPC分类号： A61K35/34 , A61K9/20 , A61K35/36 , A61K36/236 , A61K36/725 , A61K36/285 , A61K36/23 , A61K35/35 , A61K36/734
CPC分类号： A61K35/34 , A61K9/14 , A61K9/20 , A61K9/2095 , A61K35/32 , A61K35/35 , A61K35/36 , A61K36/23 , A61K36/236 , A61K36/285 , A61K36/725 , A61K36/734 , A61K2300/00
摘要： A traditional Chinese medicine complex composite for significantly improving high density lipoprotein (HDL) concentration in serum, includes: a tablet which includes 30%-50% hawthorn from north China, 10%-30% radix aucklandiae, 10%-30% radix glehniae and 10%-30% ligusticum wallichii; and a powder which includes 40%-60% beef, 15%-35% bovine sinew, 15%-35% pigskin and 0.5%-2.5% Chinese-date. The tablet is prepared by decocting and boiling the raw material medicine with water, and the powder is prepared by catalytic hydrolysis with an enzyme, the pigskin in the powder can be replaced with bovine skin or donkey skin, and the bovine sinew can be replaced with bovine tendon.
摘要翻译： 一种用于显着提高血清中高密度脂蛋白（HDL）浓度的中药复合复合材料，包括：含有华北30％-50％山楂，10％-30％紫堇，10％-30％甘草的片剂 和10％-30％的枸杞子; 和一种粉末，包括40％-60％的牛肉，15％-35％的牛皮，15％-35％的猪皮和0.5％-2.5％的中国日。 片剂通过用水煎煮原料药制成，粉末通过酶的催化水解制备，粉末中的猪皮可以用牛皮或驴皮代替，牛皮可以用 牛腱
-
公开(公告)号：US20180303888A1
公开(公告)日：2018-10-25
申请号：US15771659
申请日：2016-11-04
申请人： KOLMAR KOREA
发明人： Yong-baik CHO , Seul-ki KIM , Sang-Back KIM , Jae-hyuck SHIN , Young-ran UM , So-youn MOK , Ju-ri JUNG , Soon-min LIM , Chae Shin SEO , Hong Koo CHO , Bon Am KOO , Hyo Jin JEON , Han-Seok CHOI , Ye Jin KIM
IPC分类号： A61K36/285 , A23L33/105 , A61P1/00 , A61K36/185 , A61K36/9068 , A61K9/00
CPC分类号： A61K36/285 , A23L33/105 , A23V2002/00 , A61K9/0053 , A61K9/0056 , A61K36/185 , A61K36/28 , A61K36/9068 , A61K2236/331 , A61K2236/333 , A61P1/00
摘要： Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.
-
公开(公告)号：US20180105582A1
公开(公告)日：2018-04-19
申请号：US15686675
申请日：2017-08-25
IPC分类号： C07K16/10 , A23L33/105 , A61K35/20 , A61K36/285 , C07K16/04
CPC分类号： C07K16/1045 , A23C9/00 , A23C9/20 , A23L33/105 , A61K35/20 , A61K36/28 , A61K36/285 , A61K2039/53 , C07K16/04 , C07K2317/12 , C07K2317/22 , C07K2317/569 , C07K2317/76
摘要： A therapeutic composition can include an herbal composition having solid material or liquid extracts from the solid material of at least one of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The solid material may include one or more of parts or the whole of the stem, the bark, the flowers and the roots of one or more, but preferably all of Saussurea acrophila Diels, Saussurea ceratocarpa, and Aucklandia lappa Decne. The therapeutic composition can include camel milk, alone, or in combination with the herbal composition. The camel milk can be HIV-immunized camel milk. The HIV-immunized camel milk can be obtained by immunizing a camel against HIV by administering to the camel the modified DNA plasmids of SEQ. ID No.: 3 and SEQ ID No.: 4 and obtaining the milk from the immunized camel.
-
公开(公告)号：US20180103648A1
公开(公告)日：2018-04-19
申请号：US15617995
申请日：2017-06-08
IPC分类号： A01N65/12 , A01N65/08 , A61K36/285 , A61K36/185 , A61K9/00 , A61K9/10 , A61K9/68 , A61K9/14 , A61K8/97 , A61Q11/00
CPC分类号： A01N65/12 , A01N65/00 , A01N65/08 , A61K8/97 , A61K9/0053 , A61K9/0056 , A61K9/0058 , A61K9/08 , A61K9/10 , A61K9/14 , A61K36/185 , A61K36/285 , A61Q11/00 , A61K2300/00
摘要： An anti-microbial composition includes an extract of at least one of Aucklandia lappa Decne and Punica granatum. The extract can be an aqueous ethanol extract. The extract can be formed using the peel of the pomegranate and the root of the Aucklandia lappa Decne. A weight ratio of the Aucklandia lappa Decne and Punica granatum in the composition can range from about 4:1 to about 1:1.
-
公开(公告)号：US09861664B2
公开(公告)日：2018-01-09
申请号：US14771505
申请日：2014-06-12
申请人： Zhuangcun Gao , Xiangyu Gao
发明人： Zhuangcun Gao , Xiangyu Gao
IPC分类号： A61K36/236 , A61K36/734 , A61K36/285 , A61K35/02 , A61K35/34 , A61K35/32 , A61K35/36 , A61K36/23 , A61K36/725 , A61K9/20 , A61K35/35 , A61K9/14
CPC分类号： A61K35/34 , A61K9/14 , A61K9/20 , A61K9/2095 , A61K35/32 , A61K35/35 , A61K35/36 , A61K36/23 , A61K36/236 , A61K36/285 , A61K36/725 , A61K36/734 , A61K2300/00
摘要： A traditional Chinese medicine complex composite for significantly improving high density lipoprotein (HDL) concentration in serum, includes: a tablet which includes 30%-50% hawthorn from north China, 10%-30% radix aucklandiae, 10%-30% radix glehniae and 10%-30% ligusticum wallichii; and a powder which includes 40%-60% beef, 15%-35% bovine sinew, 15%-35% pigskin and 0.5%-2.5% Chinese-date. The tablet is prepared by decocting and boiling the raw material medicine with water, and the powder is prepared by catalytic hydrolysis with an enzyme, the pigskin in the powder can be replaced with bovine skin or donkey skin, and the bovine sinew can be replaced with bovine tendon.
-
9.发明申请公开(公告)号：US20170319607A1
公开(公告)日：2017-11-09
申请号：US15646342
申请日：2017-07-11
申请人： EDWARD KANE , PATRICIA KANE , BRETT T. HAUSER
发明人： EDWARD KANE , PATRICIA KANE , BRETT T. HAUSER
IPC分类号： A61K31/685 , A61K31/454 , A61K31/352 , A61K31/683 , A61K31/202
CPC分类号： A61K31/685 , A61K9/1277 , A61K31/05 , A61K31/202 , A61K31/352 , A61K31/353 , A61K31/454 , A61K31/661 , A61K31/6615 , A61K31/683 , A61K36/185 , A61K36/285 , A61K45/06 , A61K2300/00
摘要： This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.015 秒)
